MedPath

Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers

Not Applicable
Recruiting
Conditions
Hereditary Breast and Ovarian Cancer
Interventions
Behavioral: Structured exercise training plus mediterranean diet
Registration Number
NCT02516540
Lead Sponsor
Technical University of Munich
Brief Summary

The hypothesis of this 3 year, prospective randomized multicenter efficacy trial is that a structured life-style intervention program with exercise training and mediterranean diet is effective regarding increased adherence to a mediterranean diet, reduction of body mass index, and increase of physical fitness.

Detailed Description

BRCA1/2 mutation carriers have a considerably increased risk to develop breast and ovarian cancer during their lifetime. There is evidence from the literature that for sporadic breast cancer disease risk and the course of disease can be significantly influenced by physical activity, nutrition and weight. The hypothesis of this 3 year, prospective randomized multicenter efficacy trial is that a structured life-style intervention program with exercise training and mediterranean diet is effective regarding increased adherence to a mediterranean diet, reduction of body mass index, and increase of physical fitness.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
600
Inclusion Criteria
  • proven pathogenic BRCA1/2 mutation
  • age >=18
  • written informed consent
Exclusion Criteria
  • current chemotherapy of radiotherapy (inclusion 6 weeks after CTX or RX possible)
  • metastatic tumor disease
  • life expectancy <3 years
  • clinically limiting cardiovascular or respiratory disease (instable CVD, heart failure stage IV, COPD GOLD IV, maximum resting blood pressure 160/100 mmHg)
  • significant orthopedic disability which prevents from participating in the group interventions
  • severe concomitant diseases which prevents from participating in the group interventions
  • Karnofsky index <60
  • maximum exercise capacity <50 W
  • food allergies which prevent from mediterranean diet
  • vegan diet
  • body mass index <15 kg/m2
  • pregnancy
  • insufficient knowledge of German language
  • insufficient compliance
  • active participation in other interventional trials

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionStructured exercise training plus mediterranean dietStructured exercise training plus mediterranean diet: Study participants receive a lifestyle intervention of 12 months duration (3 months intensive intervention plus 9 months maintenance using monthly contacts and meetings). The intervention comprises a structured intensified training based on the results of physical performance diagnostics and a nutrition program based on a mediterranean diet.
Primary Outcome Measures
NameTimeMethod
body mass index (BMI)12 months

Body weight (in kilograms) divided by body height (in meters) squared.

ventilatory threshold 1 (VT1) in spiroergometry12 months

ventilatory threshold VT1 in spiroergometry

Mediterranean Diet Adherence Screener (MEDAS) Score (Questionnaire)12 months

Adherence to mediterranean diet

Secondary Outcome Measures
NameTimeMethod
stress coping capacity, as measured by the Trier Inventory for Chronic Stress (TICS) questionnaire3, 12, 24, 36 months

(TICS) questionnaire

maximum oxygen consumption (VO2max), as measured by spiroergometry3, 12 months

spiroergometry

body mass index (BMI)3, 12, 24, 36 months

(BMI)

satisfaction (questionnaire)3, 12, 24, 36 months

satisfaction (questionnaire)

physical activity, as measured by the International Physical Activity Questionnaire (IPAQ)3, 12, 24, 36 months

Physical Activity

incidence of breast cancer12, 24, 36 months

During study

Mediterranean Diet Adherence Screener (MEDAS) Score3, 6, 9, 12, 24, 36 months

(MEDAS) Score

Omega 3 fatty acid in the erythrocyte Membrane, Omega 6 fatty acid level in the erythrocyte Membraserum low density, lipoprotein cholesterolne, Omega 9 fatty acid level in the erythrocyte Membrane,3, 12, 24, 36 months

Blood Test

grade of optimism, as measured by the Life Orientation Test (LOT) questionnaire3, 12, 24, 36 months

Life Orientation Test (LOT)

attitudes and beliefs regarding physical training and healthy diet, as measured by the "Bewertung körperlicher Aktivität und Ernährung" (BKAE) questionnaire3, 12, 24, 36 months

(BKAE) questionnaire

quality of life, as measured by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30)3, 12, 24, 36 months

(EORTC QLQ-C30)

change of maximum oxygen consumption (VO2max) at ventilation threshold 1 (VT1), as measured by spiroergometry3, 12 months

spiroergometry

mortality rate12, 24, 36 months

During study

tobacco consumption12, 24, 36 months

survey

alcohol consumption12, 24, 36 months

survey

dietary habits and calory intake, as measured by the European Prospective Investigation into Cancer and Nutrition Study Food Frequency Questionnaire (EPIC-FFQ)3, 12, 24, 36 months

(EPIC-FFQ)

serum cholesterol, serum high density lipoprotein cholesterol,serum, serum Glucose, triglycerides, c-reactive Protein, serum Insulin,proneurotensin3, 12, 24, 36 months

Blood Test

proenkephalin3, 12, 24, 36 months

Genetic test

Trial Locations

Locations (19)

Universitätsmedizin Göttingen

🇩🇪

Göttingen, Germany

Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden

🇩🇪

Dresden, Germany

Universitätsklinikum Würzburg

🇩🇪

Würzburg, Germany

Universitätsklinikum Düsseldorf

🇩🇪

Düsseldorf, Germany

Humboldt Universität zu Berlin

🇩🇪

Berlin, Germany

Kliniken Essen-Mitte

🇩🇪

Essen, Germany

Universitätsklinikum Essen

🇩🇪

Essen, Germany

Universität Regensburg

🇩🇪

Regensburg, Germany

Universitätsklinikum Tübingen

🇩🇪

Tübingen, Germany

Universität Ulm

🇩🇪

Ulm, Germany

Universitätsklinikum Freiburg

🇩🇪

Freiburg, Germany

Medizinische Hochschule Hannover

🇩🇪

Hannover, Germany

Universitätsklinikum Schleswig-Holstein, Campus Kiel

🇩🇪

Kiel, Germany

Uniklinikum Köln

🇩🇪

Köln, Germany

Technische Universität München

🇩🇪

München, Germany

Interdisziplinäres Brustzentrum am Diakonieklinikum

🇩🇪

Stuttgart, Germany

Universitätsklinium Heidelberg

🇩🇪

Heidelberg, Germany

Universitätsklinikum Leipzig

🇩🇪

Leipzig, Germany

Universitätsklinikum Hamburg-Eppendorf

🇩🇪

Hamburg, Germany

© Copyright 2025. All Rights Reserved by MedPath